Tellurian Inc. (TELL): Price and Financial Metrics


Tellurian Inc. (TELL)

Today's Latest Price: $3.29 USD

0.23 (-6.53%)

Updated Jan 27 8:54am

Add TELL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 111 in Energy - Oil & Gas

See all "A" rated Strong Buy stocks

TELL Stock Summary

  • With a price/sales ratio of 30.65, Tellurian Inc has a higher such ratio than 92.1% of stocks in our set.
  • Revenue growth over the past 12 months for Tellurian Inc comes in at 76.44%, a number that bests 93.04% of the US stocks we're tracking.
  • The volatility of Tellurian Inc's share price is greater than that of 88.48% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Tellurian Inc, a group of peers worth examining would be AGFS, GPRK, NEXA, ASH, and KOS.
  • Visit TELL's SEC page to see the company's official filings. To visit the company's web site, go to www.tellurianinc.com.

TELL Stock Price Chart Interactive Chart >

Price chart for TELL

TELL Price/Volume Stats

Current price $3.29 52-week high $7.97
Prev. close $3.52 52-week low $0.67
Day low $3.29 Volume 914,951
Day high $3.29 Avg. volume 22,051,469
50-day MA $1.63 Dividend yield N/A
200-day MA $1.19 Market Cap 1.09B

Tellurian Inc. (TELL) Company Bio


Tellurian Inc., formerly known as Magellan Petroleum Corporation, plans to build a natural gas business that includes 26 mtpa production from Driftwood LNG, trading of LNG cargoes, and development of new markets globally.


TELL Latest News Stream


Event/Time News Detail
Loading, please wait...

TELL Latest Social Stream


Loading social stream, please wait...

View Full TELL Social Stream

Latest TELL News From Around the Web

Below are the latest news stories about Tellurian Inc that investors may wish to consider to help them evaluate TELL as an investment opportunity.

Thinking about buying stock in Acer Therapeutics, Zomedica, Novan, Atossa Therapeutics, or Tellurian?

NEW YORK, Jan. 25, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACER, ZOM, NOVN, ATOS, and TELL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….

PR Newswire | January 25, 2021

Tellurian: Market Attracted By The Fundamentals

Finding exceptional stocks with low valuations is very difficult even at the best of times. Stocks which are very cheap are inexpensive for a reason. The challenge here many times is knowing if and when the respective company will turn itself around. Time is money. In essence, if one has...

Individual Trader on Seeking Alpha | January 22, 2021

Tellurian aims for Louisiana LNG construction start this summer

The co-founder of U.S. LNG developer Tellurian said Thursday that the company is targeting this summer to begin construction of its US$16.8 billion Driftwood LNG export project in Louisiana as demand for the super-cooled fuel surges worldwide.

Channel NewsAsia | January 15, 2021

Is ExxonMobil's $20 Billion Writedown Bad News for LNG Stocks?

Earlier this month, oil giant ExxonMobil (NYSE: XOM) announced that it was going to take a massive $20 billion writedown. A substantial portion of that writedown is tied to a big investment the company made in natural gas a number of years ago that worked out terribly. At the same time, the company's management has decided to prioritize its capital investments going forward, focusing on oil assets it thinks will deliver the best returns.

Yahoo | December 18, 2020

Tellurian (TELL) Drops Its Permian Pipeline Building Plans

Tellurian (TELL) withdraws its application to build Permian Global Access Pipeline as the pandemic-induced demand destruction caused the global energy prices to collapse.

Yahoo | December 3, 2020

Read More 'TELL' Stories Here

TELL Price Returns

1-mo 147.37%
3-mo 263.98%
6-mo 268.92%
1-year -54.27%
3-year -71.93%
5-year 344.59%
YTD 157.03%
2020 -82.42%
2019 4.75%
2018 -28.64%
2017 -13.42%
2016 1,945.45%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9147 seconds.